MEI Pharma, Inc. (MEIP) is primed for evolution with the beta value of 1.82

MEI Pharma, Inc. (MEIP) is priced at $3.39 after the most recent trading session. At the very opening of the session, the stock price was $3.23 and reached a high price of $3.51, prior to closing the session it reached the value of $3.23. The stock touched a low price of $3.1.

MEI Pharma, Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.64 on 04/14/20, with the lowest value was $0.72 for the same time period, recorded on 03/19/20.

MEI Pharma, Inc. (MEIP) full year performance was 11.51%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, MEI Pharma, Inc. shares are logging -6.87% during the 52-week period from high price, and 370.83% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.72 and $3.64.

The company’s shares, operating in the sector of healthcare managed to top a trading volume set approximately around 2.03 million for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the MEI Pharma, Inc. (MEIP) recorded performance in the market was 36.69%, having the revenues showcasing 43.04% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 367.41M, as it employees total of 40 workers.

Market experts do have their say about MEI Pharma, Inc. (MEIP)

During the last month, 5 analysts gave the MEI Pharma, Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 2.16, with a change in the price was noted +1.22. In a similar fashion, MEI Pharma, Inc. posted a movement of +55.86% for the period of last 100 days, recording 1,408,230 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity. The total Debt to Equity ratio for MEIP is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical breakdown of MEI Pharma, Inc. (MEIP)

Raw Stochastic average of MEI Pharma, Inc. in the period of last 50 days is set at 91.44%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 90.00%. In the last 20 days, the company’s Stochastic %K was 88.32% and its Stochastic %D was recorded 84.61%.

Bearing in mind the latest performance of MEI Pharma, Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 36.69%. Additionally, trading for the stock in the period of the last six months notably improved by 92.61%, alongside a boost of 11.51% for the period of the last 12 months. The shares increased approximately by 4.56% in the 7-day charts and went down by 14.33% in the period of the last 30 days. Common stock shares were driven by 43.04% during last recorded quarter.